Seroepidemiologies of human metapneumovirus and respiratory syncytial virus in young children, determined with a new recombinant fusion protein enzyme-linked immunosorbent assay

Sarah R. Dunn, Alex Ryder, Sharon J. Tollefson, Meng Xu, Benjamin R. Saville, John V. Williams

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

We compared antibodies against human metapneumovirus (HMPV) and respiratory syncytial virus (RSV) in children. The antibody nadirs for both viruses were at 3 to 5 months, and the majority of children were seropositive for both by 2 years. There was no significant difference in the kinetics of maternal antibody decline or seroconversion relative to the two viruses.

Original languageEnglish (US)
Pages (from-to)1654-1656
Number of pages3
JournalClinical and Vaccine Immunology
Volume20
Issue number10
DOIs
StatePublished - Oct 1 2013

Fingerprint

Human respiratory syncytial virus
Metapneumovirus
Recombinant Fusion Proteins
Immunosorbents
Viruses
Assays
Enzyme-Linked Immunosorbent Assay
Antibodies
Enzymes
Mothers
Kinetics

All Science Journal Classification (ASJC) codes

  • Immunology and Allergy
  • Immunology
  • Clinical Biochemistry
  • Microbiology (medical)

Cite this

Seroepidemiologies of human metapneumovirus and respiratory syncytial virus in young children, determined with a new recombinant fusion protein enzyme-linked immunosorbent assay. / Dunn, Sarah R.; Ryder, Alex; Tollefson, Sharon J.; Xu, Meng; Saville, Benjamin R.; Williams, John V.

In: Clinical and Vaccine Immunology, Vol. 20, No. 10, 01.10.2013, p. 1654-1656.

Research output: Contribution to journalArticle

@article{45c63d82df2f498da3e1607cd25653e0,
title = "Seroepidemiologies of human metapneumovirus and respiratory syncytial virus in young children, determined with a new recombinant fusion protein enzyme-linked immunosorbent assay",
abstract = "We compared antibodies against human metapneumovirus (HMPV) and respiratory syncytial virus (RSV) in children. The antibody nadirs for both viruses were at 3 to 5 months, and the majority of children were seropositive for both by 2 years. There was no significant difference in the kinetics of maternal antibody decline or seroconversion relative to the two viruses.",
author = "Dunn, {Sarah R.} and Alex Ryder and Tollefson, {Sharon J.} and Meng Xu and Saville, {Benjamin R.} and Williams, {John V.}",
year = "2013",
month = "10",
day = "1",
doi = "10.1128/CVI.00750-12",
language = "English (US)",
volume = "20",
pages = "1654--1656",
journal = "Clinical and Vaccine Immunology",
issn = "1556-6811",
publisher = "American Society for Microbiology",
number = "10",

}

TY - JOUR

T1 - Seroepidemiologies of human metapneumovirus and respiratory syncytial virus in young children, determined with a new recombinant fusion protein enzyme-linked immunosorbent assay

AU - Dunn, Sarah R.

AU - Ryder, Alex

AU - Tollefson, Sharon J.

AU - Xu, Meng

AU - Saville, Benjamin R.

AU - Williams, John V.

PY - 2013/10/1

Y1 - 2013/10/1

N2 - We compared antibodies against human metapneumovirus (HMPV) and respiratory syncytial virus (RSV) in children. The antibody nadirs for both viruses were at 3 to 5 months, and the majority of children were seropositive for both by 2 years. There was no significant difference in the kinetics of maternal antibody decline or seroconversion relative to the two viruses.

AB - We compared antibodies against human metapneumovirus (HMPV) and respiratory syncytial virus (RSV) in children. The antibody nadirs for both viruses were at 3 to 5 months, and the majority of children were seropositive for both by 2 years. There was no significant difference in the kinetics of maternal antibody decline or seroconversion relative to the two viruses.

UR - http://www.scopus.com/inward/record.url?scp=84886738768&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84886738768&partnerID=8YFLogxK

U2 - 10.1128/CVI.00750-12

DO - 10.1128/CVI.00750-12

M3 - Article

VL - 20

SP - 1654

EP - 1656

JO - Clinical and Vaccine Immunology

JF - Clinical and Vaccine Immunology

SN - 1556-6811

IS - 10

ER -